Technology News and Research

RSS

RoundTable signs agreement to acquire Ophthalmic Systems business unit

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that is has entered into an agreement with BD to acquire the Ophthalmic Systems unit, a business within the BD Medical segment. BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents.

9 Jun 2010

IBM, ProtonMedia enter teaming agreement for 3-D virtual collaboration platform

IBM and ProtonMedia have entered into a teaming agreement that will result in the delivery of innovative, 3-D virtual collaboration and communication solutions engineered specifically for global life sciences organizations. Under the terms of the agreement, ProtonMedia's ProtoSphere technology will be the basis for customized, 3-D virtual collaboration environments to create high-performance workplaces.

9 Jun 2010

Fluidigm develops world's first reusable bio-chip architecture

Fluidigm Corporation today announced it has developed the world's first reusable bio-chip architecture for the commercial market. These reusable integrated fluidic circuits (IFCs) will dramatically lower SNP genotyping costs and are designed to support accelerated sample throughput, while maintaining data quality of 99.75 percent or greater accuracy and 99 percent or greater call rates.

9 Jun 2010

Insulin delivery devices help diabetic patients optimize blood glucose control, minimize chronic health problems

The growing use of insulin delivery devices such as pens and pumps may help individuals with diabetes optimize blood glucose control and minimize their risk for chronic health problems associated with diabetes, as described in a Special Supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc.

9 Jun 2010

Siemens Healthcare to resell SSI's ClickON LinX technology

The SSI Group, Inc. (SSI) announced today that they have entered into a Value-Added Reseller agreement with Siemens Healthcare, Malvern, PA. The agreement enables Siemens Healthcare to sell SSI's industry leading ClickON® LinX technology, which provides patient claims editing and transmission for healthcare providers.

9 Jun 2010

DSM announces agreements with Biomedical Structures, Cortland and Secant Medical

DSM, which created and manufactures Dyneema Purity, the world's strongest Medical grade fiber, today announced agreements with Biomedical Structures, Cortland Company and Secant Medical. These companies' experience in processing Dyneema Purity fiber in biomedical textile structures offers medical device companies the ability to use various constructions of Dyneema Purity, including the recently launched Dyneema Purity BLUE, in commercial medical devices.

9 Jun 2010

Cellectis bioresearch, Lonza collaborate in development, commercialization of bioengineered cell line

Cellectis bioresearch, the French genome customization specialist and a commercial subsidiary of Cellectis, and Lonza, a world leader in biotechnology production, announce today that the companies have entered into an agreement for the development and commercialization of a bioengineered cell line.

9 Jun 2010

Biogen, Elan launch My MS Health, a web-based PRO research program

Biogen Idec and Elan Corporation, plc, in collaboration with EPI-Q, Inc. and Avatar International, LLC, today announced the launch of My MS Health, a first-of-its-kind, web-based, patient-reported outcomes research program. My MS Health is designed to track and provide instant reports on patient function and quality of life using validated measures over time.

9 Jun 2010

Argos presents positive AGS-003 Phase 2 data for newly diagnosed advanced renal cell carcinoma at ASCO

Argos Therapeutics today announced the presentation of positive interim data from a Phase 2 trial that evaluated the clinical activity, safety and immune response of AGS-003 treatment, given in combination with sunitinib, in patients with newly diagnosed advanced renal cell carcinoma (RCC). The data were discussed June 7 in a poster session at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

8 Jun 2010

Immunomedics reports encouraging results from TF2 Phase I studies for colorectal cancer

Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that TF2, a proprietary bispecific antibody, has shown selective tumor localization and minimal normal tissue retention in two early Phase I studies in patients with colorectal cancer.

8 Jun 2010

Princeton University president named 2010 winner of Henry G. Friesen International Prize in Health Research

Internationally renowned scientist and scholar Shirley M. Tilghman, president of Princeton University, was named the 2010 winner of the Henry G. Friesen International Prize in Health Research.

8 Jun 2010

NexGen Biomedical offers RNAi / PSR platform technology for sale

NexGen Biomedical, Inc. announced today that it is offering its RNAi / PSR platform technology for sale. "While technologies like siRNA are well suited for disease conditions involving expression of a single protein, the RNAi / PSR technology is better suited for conditions involving expression of a broad spectrum of proteins such as happens with cell hyperproliferation, inflammation, and viral infections.

8 Jun 2010

BD to sell certain assets of Medical segment

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has signed agreements to sell certain assets of its BD Medical segment, including the Ophthalmic Systems unit as well as the surgical blades, critical care and extended dwell catheter product platforms of the Medical Surgical Systems unit.

From BD (Becton, Dickinson and Company) 8 Jun 2010

FDA grants CryoLife 510(k) clearance for shelf-life extension of CryoValve SG pulmonary heart valve

CryoLife, Inc., a biomaterials, medical device and tissue processing company, today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for a five-year shelf-life on its CryoValve® SG pulmonary human heart valve processed with the Company's proprietary SynerGraft® technology.

8 Jun 2010

Xenex Healthcare Services announces commercial launch of pulsed xenon room disinfection system

Xenex Healthcare Services LLC, which specializes in developing disinfection technology for healthcare facilities, today announced the commercial launch of its pulsed xenon room disinfection system and the conclusion of the Xenex system's successful trial at a leading U.S. cancer center. The Xenex system, which is now available, is the fastest, safest, and most effective method for the advanced cleaning of hospital rooms in the world today, quickly destroying all major classes of microorganisms (including viruses, bacteria and bacterial spores) without contact or chemicals.

8 Jun 2010

ZixCorp announces new, 3-year email encryption contract with Orlando Health

Zix Corporation, the leader in email encryption services, has announced a new, three-year contract with Orlando Health, a $1.5 billion not-for-profit health care organization and a community-based network of hospitals and care centers in the Orlando region.

8 Jun 2010

RealMed signs multi-year agreement with MED3OOO

RealMed Corporation, a leading provider of web-based revenue cycle management solutions for healthcare providers, hospitals, and payers, today announced a multi-year agreement with MED3OOO, a national leader in providing advanced healthcare management and technologies to physicians. RealMed will provide secure, Internet-based, real-time adjudication and processing of electronic claims transactions, real-time claims editing, automatic claims status and electronic remittance advice management.

8 Jun 2010

Protalix BioTherapeutics reports positive results from PRX-105 Phase I clinical trial

Protalix BioTherapeutics, Inc. announced today the completion of its phase I clinical trial of PRX-105, a plant cell expressed pegylated recombinant human acetylcholinesterase in development for biodefense indications. The trial established the pharmacokinetics of the protein and demonstrated that single dose, intravenous administration of PRX-105 is safe and well tolerated.

8 Jun 2010

USPTO grants ISCO patent to International Stem Cell's hpSC

International Stem Cell Corporation, www.intlstemcell.com, announced today that the United States Patent and Trademark Office has granted ISCO patent number 7,732,202, the first of several pending patents relating to its development of human parthenogenetic Stem Cells. Human parthenogenetic stem cells are a new type of pluripotent stem cell that allows immune matching to potentially solve critical immune rejection problems, and does not involve the ethical issues that surround the use of fertilized human embryos.

8 Jun 2010

Research project to transform primary care practices into patient-centered medical homes concludes

An unprecedented research project into how to transform primary care practices into patient-centered medical homes has concluded with the release of a new eight-paper supplement to the May/June issue of Annals of Family Medicine.

8 Jun 2010

Technology News and Research

RoundTable signs agreement to acquire Ophthalmic Systems business unit

IBM, ProtonMedia enter teaming agreement for 3-D virtual collaboration platform

Fluidigm develops world's first reusable bio-chip architecture

Insulin delivery devices help diabetic patients optimize blood glucose control, minimize chronic health problems

Siemens Healthcare to resell SSI's ClickON LinX technology

DSM announces agreements with Biomedical Structures, Cortland and Secant Medical

Cellectis bioresearch, Lonza collaborate in development, commercialization of bioengineered cell line

Biogen, Elan launch My MS Health, a web-based PRO research program

Argos presents positive AGS-003 Phase 2 data for newly diagnosed advanced renal cell carcinoma at ASCO

Immunomedics reports encouraging results from TF2 Phase I studies for colorectal cancer

Princeton University president named 2010 winner of Henry G. Friesen International Prize in Health Research

NexGen Biomedical offers RNAi / PSR platform technology for sale

BD to sell certain assets of Medical segment

FDA grants CryoLife 510(k) clearance for shelf-life extension of CryoValve SG pulmonary heart valve

Xenex Healthcare Services announces commercial launch of pulsed xenon room disinfection system

ZixCorp announces new, 3-year email encryption contract with Orlando Health

RealMed signs multi-year agreement with MED3OOO

Protalix BioTherapeutics reports positive results from PRX-105 Phase I clinical trial

USPTO grants ISCO patent to International Stem Cell's hpSC

Research project to transform primary care practices into patient-centered medical homes concludes

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News